Updated weekly ・ last 2026-10-03JAEN
Pharma Promotion / Incidents by company / Astellas

Astellas

10 incidents / jurisdictions: United Kingdom, United States / sum of amounts reported: USD 232.3 m

DateJurisdictionOutcomeWhat happened (source)Damages / settlement / fine
2023-05-03United StatesOtherAstellas US Holding, Inc. v. Federal Insurance Company
Court of Appeals for the Seventh Circuit
—
2019-07-02United KingdomIndustry-code breach rulingThe whistleblowing drama behind Astellas’s suspension from the ABPI
BMJ
—
2019-04-25United StatesSettlementTwo Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations That They Paid Kickbacks Through Copay Assistance Foundations
U.S. Department of Justice + 1 more reports
$125 Million / $124.75 million
2019-04-03United StatesFiled / under investigationUnited States ex rel. Streck v. Takeda Pharm. Am., Inc.
District Court, E.D. Illinois
—
2019United StatesSettlementIn April 2019, Astellas agreed to pay the United States Department of Justice $100 million to resolve allegations that it had conspired to offer kickbacks via Medicare copay foundations.
Wikipedia: Astellas Pharma(Controversies)
$100 million
2018United KingdomIndustry-code breach rulingIn December 2018, the Prescription Medicines Code of Practice Authority (PMCPA) published their findings following an allegation that Astellas had "inappropriately awarded research funding" to a senio
Wikipedia: Astellas Pharma(Controversies)
—
2017United KingdomIndustry-code breach rulingIn May 2017, the ABPI extended the suspension by a further 12 months, based on findings that Astellas was not adequately overseeing and training nurses, and that it had failed to provide complete pres
Wikipedia: Astellas Pharma(Controversies)
—
2017United KingdomIndustry-code breach rulingIn June 2017, Astellas was reprimanded for "producing a large number of promotional materials, which had been used for a number of years, that did not include the required prescribing information rela
Wikipedia: Astellas Pharma(Controversies)
—
2016United KingdomIndustry-code breach rulingIn June 2016, the Association of the British Pharmaceutical Industry (ABPI) gave Astellas a year-long suspension, after complaints it had "purposely misled the PMCPA (Prescription Medicines Code of Pr
Wikipedia: Astellas Pharma(Controversies)
—
2014-04-16United StatesSettlementAstellas Pharma US, Inc. To Pay $7.3 Million To Resolve False Claims Act Allegations
U.S. Department of Justice
$7.3 Million
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.